Back

GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: con

29 August 2025 (14:05 - 14:25)
Organised by: Logo
Congress Presentation Part of: Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: pro
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
GLP-1 receptor agonists and muscle loss: mechanisms and discussion

Access the full session

Session thumbnail
Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease?
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 14:05 CET
You may be interested in
thumbnail
Congress Session
Great Debate: do GLP-1 analogues/GLP-1 receptor agonists (GLP-1RAs) worsen muscle loss in cardiometabolic disease?
thumbnail
Congress Presentation
GLP-1 receptor agonists therapy induces muscle loss in cardiometabolic disease: pro
thumbnail
Congress Session
Great Debate: tackling the obesity tsunami - are GLP-1 drugs the solution?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources